Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$21.40 USD
-0.09 (-0.42%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $21.33 -0.07 (-0.33%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $-0.11 | 0.00% |
Earnings Summary
For their last quarter, Myriad Genetics (MYGN) reported earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This reflects a positive earnings surprise of 100.00%. Look out for MYGN's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 47.62%.
Earnings History
Price & Consensus
Zacks News for MYGN
Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services